Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences Research

 

Professor Richard Cannon, Associate Dean (Research)

Richard Canon May 2016 Professor Richard Cannon has been selected as the new Associate Dean Research for the Division. Richard has been the Director of the Sir John Walsh Research Institute and the Associate Dean Research for the Faculty of Dentistry for the past 3 years.

Trained as a Microbiologist, Richard has an extensive understanding of the research system in New Zealand, having himself sustained a large research group for over twenty years. He and his group have successfully attracted funding from HRC, MBIE, Marsden fund, NIH and commercial partnerships both nationally and overseas. As Richard has been a member of the Division of Health Sciences Research Committee for a number of years, he is very well placed to continue to lead divisional initiatives.

Contact

Professor Richard Cannon
Associate Dean (Research)
Tel 64 3 479 7081
Email richard.cannon@otago.ac.nz

^ Top of Page

Professor Paul Glue, Associate Dean (Research Commercialisation)

Professor Paul GluePaul Glue is Professor of Psychological Medicine in the Dunedin School of Medicine, within Otago Medical School at the University of Otago. He graduated MBChB from the University of Otago. He completed his psychiatry training (MRCPsych) in Oxford UK, and was elected FRCPsych in 2010. In 1987 he moved to the US National Institutes of Health for preclinical neuroscience research and completed an MD in clinical psychopharmacology at the University of Bristol, UK in 1992. Since 2009 he has also been working as a consultant psychiatrist for the Southern District Health Board, in adult general psychiatry.

He was involved with translational clinical pharmacology research in the pharmaceutical industry for 18 years (Schering-Plough, Novartis, Pfizer). He has published over 400 papers and abstracts, has 11 patents and several international research awards / prizes. He was involved with the successful development of a number of drugs including pegylated interferon alfa-2b, interferon-ribavirin combinations for chronic hepatitis C, fingolimod for multiple sclerosis, and combination buprenorphine-naltrexone for opioid maintenance treatment. His current research areas include clinical pharmacology, psychopharmacology and clinical trial design. Current active research interests include use of ketamine for treatment-resistant depression and anxiety disorders.

Paul works with the Pro-Vice-Chancellor (Health Sciences) to promote research commercialisation activities in the Division of Health Sciences. Commercialisation of research is about developing new intellectual property from our research into products and services, thereby contributing to the knowledge-based economy of New Zealand. It is also about building links with industry through knowledge transfer (consulting, commercial research contracts) and technology transfer to enhance the product / services of existing companies. These activities require intimate interaction with the University’s Research and Enterprise Office and Otago Innovation Ltd. Together with senior colleagues in the Divisions of Sciences and Health Sciences, Paul aims to encourage and support staff and research students to be involved in commercialisation of their research.

Contact

Professor Paul Glue
Associate Dean (Research Commercialisation)
Tel +64 3 470 9430
Email paul.glue@otago.ac.nz

^ Top of Page

Dr Michele Coleman, Research and Development Manager

After completing her PhD on the PrP protein associated with bovine spongiform encephalopathy at Edinburgh University, Michele came to Otago to complete a Marsden-funded postdoctoral fellowship in the Department of Biochemistry. Since then she has held a number of positions in the Division of Health Sciences, culminating in her present role.

Michele advises the Pro-Vice-Chancellor on all aspects of research strategy within the Division. This includes development of strategy, responses to government initiatives, and allocation of Divisional funding for research.

Contact

Dr Michele Coleman
Research and Development Manager
Tel 64 3 479 3076
Mob 64 27 2844629
Fax 64 3 479 5058
Email michele.coleman@otago.ac.nz

^ Top of Page

Dr Kerry Galvin, Scientific Officer

Kerry Galvin, Health SciencesKerry has a PhD in neurobiology from the University of Otago. Her work experience began in the Department of Anatomy, where she undertook research in neuroscience and medical ethics. She has since worked in a number of research and project management roles within the University interspersed with extended stints of overseas travel. Prior to her current role she was project manager for Otago Medical School's accreditation by the Australian Medical Council.

Kerry joined the Health Sciences Research team in 2008 and works alongside Dr Michele Coleman, the Division’s Research and Development Manager, to support all aspects of research within the Division.

Contact

Dr Kerry Galvin
Scientific Officer, Research and Development
Tel 64 3 479 9773
Email kerry.galvin@otago.ac.nz

^ Top of page

Dr Janet Rountree, Scientific Officer

Janet's role is to provide support for academic staff in the Division of Health Sciences in the preparation of Performance Based Research Funding (PBRF) Evidence Portfolios.

Her usual hours are Monday and Fridays, plus Wednesday and Thursday afternoons.

Contact

Dr Janet Rountree
Scientific Officer, Research and Development
Tel 64 3 479 5674
Email janet.rountree@otago.ac.nz

^ Top of Page

Wendy Houliston, Stakeholder Communications Advisor

Wendy is a University of Otago graduate in psychology. She works with staff to develop promotional material about research and researchers. This includes creating and maintaining websites, supporting research events, and getting good promotional mileage from activities and media attention.

Contact

Wendy Houliston
Stakeholder Communications Advisor
Tel 64 3 479 9076
Email wendy.houliston@otago.ac.nz

^ Top of Page